{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-24-001606","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2024-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.697940+00:00","generated_at":"2026-05-30T13:40:46.714544+00:00","sec_items":["3.01","5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Renovaro appoints new CEO David Weinstein; multiple board resignations including chairman","bullets":["David Weinstein (age 64) appointed CEO and board member; base salary $400k, up to $150k bonus, 250k restricted shares, 1.6M stock options.","Former CEO Mark Dybul resigned Oct 12, 2024; eight directors resigned between Oct 11-15, including chairman Rene Sindlev.","New directors appointed: Maurice van Tilburg, James McNulty, Douglas Calder, Mark Collins.","Weinstein receives $25k bonus if company secures $2M+ in new financing; severance includes 6 months' salary and accelerated equity vesting.","Resignations by James Sapirstein, Gregg Alton, Jayne McNicol, Carol Brosgart were by letters; no disagreements cited."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-24-001606","json":"https://secwatch.observer/filing/0001731122-24-001606.json","markdown":"https://secwatch.observer/filing/0001731122-24-001606.md","text":"https://secwatch.observer/filing/0001731122-24-001606.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/0001731122-24-001606-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/e6034_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T13:40:46.714544+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"00c71350d1","claim":"Avram Miller resigned as Director at Lunai Bioworks Inc..","evidence_excerpt":"On October 11, 2024, Avram Miller resigned as a director on the Board of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/0001731122-24-001606-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"01e0454920","claim":"Rene Sindlev resigned as Chairman of the Board at Lunai Bioworks Inc..","evidence_excerpt":"On October 15, 2024, Rene Sindlev resigned as the Chairman of the Board of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/0001731122-24-001606-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"0fadd41c54","claim":"David Weinstein was appointed as Director at Lunai Bioworks Inc..","evidence_excerpt":"Once Messrs. Weinstein, van Tilburg, McNulty, Calder and Collins’ Board committee membership is determined","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/0001731122-24-001606-index.htm","confidence":0.5,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"112bb62aa0","claim":"Gregg Alton resigned as Lead Independent Director at Lunai Bioworks Inc..","evidence_excerpt":"On October 13, 2024, Gregg Alton the Lead Independent Director on the Board, Jayne McNicol and Carol Brosgart formally advised the Board of the Company that they were resigning from the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/0001731122-24-001606-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Lead Independent Director"}],"fact_type":"executive_change"},{"claim_id":"3599b8411c","claim":"Douglas Calder was appointed as Director at Lunai Bioworks Inc..","evidence_excerpt":"Once Messrs. Weinstein, van Tilburg, McNulty, Calder and Collins’ Board committee membership is determined","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/0001731122-24-001606-index.htm","confidence":0.5,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"38f6ca9f33","claim":"James Sapirstein resigned as Director at Lunai Bioworks Inc..","evidence_excerpt":"On October 12, 2024, James Sapirstein a member of the Board formally advised the Board of the Company that he was resigning from the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/0001731122-24-001606-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"501395f4dc","claim":"James McNulty was appointed as Director at Lunai Bioworks Inc..","evidence_excerpt":"Once Messrs. Weinstein, van Tilburg, McNulty, Calder and Collins’ Board committee membership is determined","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/0001731122-24-001606-index.htm","confidence":0.5,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"7090d8923e","claim":"Karen Brink resigned as Director at Lunai Bioworks Inc..","evidence_excerpt":"On October 12, 2024, Karen Brink resigned as a director on the Board of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/0001731122-24-001606-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"addc6d4ff4","claim":"Carol Brosgart resigned as Director at Lunai Bioworks Inc..","evidence_excerpt":"On October 13, 2024, Gregg Alton the Lead Independent Director on the Board, Jayne McNicol and Carol Brosgart formally advised the Board of the Company that they were resigning from the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/0001731122-24-001606-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"bfd56e8480","claim":"Mark Collins was appointed as Director at Lunai Bioworks Inc..","evidence_excerpt":"Once Messrs. Weinstein, van Tilburg, McNulty, Calder and Collins’ Board committee membership is determined","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/0001731122-24-001606-index.htm","confidence":0.5,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"e4d2f099bd","claim":"Ruud Hendriks resigned as Director at Lunai Bioworks Inc..","evidence_excerpt":"On the same date, Ruud Hendriks resigned as a director on the Board of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/0001731122-24-001606-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"e8d0bcb378","claim":"Jayne McNicol resigned as Director at Lunai Bioworks Inc..","evidence_excerpt":"On October 13, 2024, Gregg Alton the Lead Independent Director on the Board, Jayne McNicol and Carol Brosgart formally advised the Board of the Company that they were resigning from the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/0001731122-24-001606-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ef633d688b","claim":"Maurice van Tilburg was appointed as Director at Lunai Bioworks Inc..","evidence_excerpt":"Once Messrs. Weinstein, van Tilburg, McNulty, Calder and Collins’ Board committee membership is determined","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/0001731122-24-001606-index.htm","confidence":0.5,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}